跳至主要内容
临床试验/KCT0003385
KCT0003385招募中未知

A pilot cohort study of autologous platelet-rich plasma in the treatment of unresponsive thin endometrium resistant to standard therapies

Bundang CHA General Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 45(Year)(—)
性别
Female

入选标准

  • (a) age of 20?45 years at the time of enrollment, (b) endometrial thickness (EMT) of <7 mm on the human chorionic gonadotropin (hCG) administration day in fresh ET cycles or on the end of estrogen priming day in frozen ET cycles in all of the previous cycles, (c) two or more failed IVF cycles, (d) more than two cycles of previous therapy for increasing the EMT, such as, hysteroscopic adhesiolysis following hormone replacement therapy, high dose estradiol valerate, transvaginal sildenafil administration, or pentoxifyilline combination with vitamin E, (e) frozen embryo available for ET, and (f) informed consent form signed.

排除标准

  • (a) hematologic disorders, hemoglobin level of <9.0 g/dL or platelet count of <100,000/µL, (b) auto-immune disease, (c) chromosomal abnormality in the patient or spouse, (d) peripheral NK cell proportion of =12%, (e) body mass index (BMI) of =30 kg/m2, and (f) uncontrolled endocrine or other medical conditions, such as prolactinemia or thyroid diseases

研究者

发起方
Bundang CHA General Hospital

相似试验